Effects of curcumin on the gene expression profile of L-02 cells

Zhou,Mingjie; Fan,Chunlei; Tian,Nan

doi:10.3892/br.2015.460

Effects of curcumin on the gene expression profile of L-02 cells

Authors:
- Mingjie Zhou
- Chunlei Fan
- Nan Tian
View Affiliations

Affiliations: College of Life Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China
Published online on: May 4, 2015 https://doi.org/10.3892/br.2015.460
Pages: 519-526

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Curcumin has been utilized in the treatment and prevention of disease, including cancer and cardiovascular disease, but the molecular mechanism behind such numerous effects remains unclear. To explore the molecular mechanism and action sites of curcumin at the cellular level, human hepatic L‑02 cells were used to assess these effects. Microarray technology was employed to detect the gene expression of L‑02 cells treated with curcumin. According to the microarray results and the data from the National Center for Biotechnology Information, the present study classified and concluded that these curcumin‑sensitive genes were associated with diseases and their signaling pathway. The study supports the evidence for treating cancer and cardiovascular disease, and found certain potential marker genes for conducting systematic research into the effects of curcumin. A total of 80 genes were identified as significantly differentially expressed between samples treated with and without curcumin. Curcumin is capable of developing physiological reactions and functions by regulating the gene expression and affecting its signal transduction pathway. Tumor protein p63, MYC‑associated factor X and certain other genes associated with tumors act on a potential therapeutic target, while apolipoprotein B receptor and oxysterol‑binding protein‑like 7, and their signaling pathways may be involved in the cardioprotective effects of curcumin.

View Figures

View References

1	Sharma RA, Steward WP and Gescher AJ: Pharmacokinetics and pharmacodynamics of curcumin. Adv Exp Med Biol. 595:453–470. 2007.PubMed/NCBI
2	Sa G and Das T: Anti cancer effects of curcumin: Cycle of life and death. Cell Div. 3:142008. View Article : Google Scholar : PubMed/NCBI
3	Aggarwal BB, Sundaram C, Malani N and Ichikawa H: Curcumin: The Indian solid gold. Adv Exp Med Biol. 595:1–75. 2007.PubMed/NCBI
4	Fan CL, Qian Y, Wo XD, Yan J and Gao LP: Effect of curcumin on the gene expression of low density lipoprotein receptors. Chin J Integr Med. 11:201–204. 2005.(In Chinese). View Article : Google Scholar : PubMed/NCBI
5	Soni KB and Kuttan R: Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol. 36:273–275. 1992.PubMed/NCBI
6	Peschel D, Koerting R and Nass N: Curcumin induces changes in expression of genes involved in cholesterol homeostasis. J Nutr Biochem. 18:113–119. 2007. View Article : Google Scholar : PubMed/NCBI
7	King HC and Sinha AA: Gene expression profile analysis by DNA microarrays: Promise and pitfalls. JAMA. 286:2280–2288. 2001. View Article : Google Scholar : PubMed/NCBI
8	Hong D, Zeng X, Xu W, Ma J, Tong Y and Chen Y: Altered profiles of gene expression in curcumin-treated rats with experimentally induced myocardial infarction. Pharmacol Res. 61:142–148. 2010. View Article : Google Scholar : PubMed/NCBI
9	Jain SK, Rains J, Croad J, Larson B and Jones K: Curcumin supplementation lowers TNF-alpha, IL-6, IL-8 and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose and glycosylated hemoglobin in diabetic rats. Antioxid Redox Signal. 11:241–249. 2009. View Article : Google Scholar : PubMed/NCBI
10	Kakar SS and Roy D: Curcumin inhibits TPA induced expression of c-fos, c-jun and c-myc proto-oncogenes messenger RNAs in mouse skin. Cancer Lett. 87:85–89. 1994. View Article : Google Scholar : PubMed/NCBI
11	Neves H, Weerkamp F, Gomes AC, et al: Effects of Delta1 and Jagged1 on early human hematopoiesis: Correlation with expression of notch signaling-related genes in CD34⁺ cells. Stem Cells. 24:1328–1337. 2006. View Article : Google Scholar : PubMed/NCBI
12	Shukla SD: Platelet-activating factor receptor and signal transduction mechanisms. FASEB J. 6:2296–2301. 1992.PubMed/NCBI
13	Balestrieri ML, Giovane A, Milone L and Servillo L: Endothelial progenitor cells express PAF receptor and respond to PAF via Ca(2+)-dependent signaling. Biochim Biophys Acta. 1801:1123–1132. 2010. View Article : Google Scholar : PubMed/NCBI
14	Anant JS, Desnoyers L, Machius M, Demeler B, Hansen JC, Westover KD, Deisenhofer J and Seabra MC: Mechanism of Rab geranylgeranylation: Formation of the catalytic ternary complex. Biochemistry. 37:12559–12568. 1998. View Article : Google Scholar : PubMed/NCBI
15	Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dötsch V, Andrews NC, Caput D and McKeon F: p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell. 2:305–316. 1998. View Article : Google Scholar : PubMed/NCBI
16	Hau PM, Yip YL, Huen MS and Tsao SW: Loss of ΔNp63α promotes mitotic exit in epithelial cells. FEBS Lett. 585:2720–2726. 2011. View Article : Google Scholar : PubMed/NCBI
17	Chen YR and Tan TH: Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene. 17:173–178. 1998. View Article : Google Scholar : PubMed/NCBI
18	Cotterman R, Jin VX, Krig SR, Lemen JM, Wey A, Farnham PJ and Knoepfler PS: N-Myc regulates a widespread euchromatic program in the human genome partially independent of its role as a classical transcription factor. Cancer Res. 68:9654–9662. 2008. View Article : Google Scholar : PubMed/NCBI
19	Khar A, Ali AM, Pardhasaradhi BV, et al: Antitumor activity of curcumin is mediated through the induction of apoptosis in AK-5 tumor cells. FEBS Lett. 445:165–168. 1999. View Article : Google Scholar : PubMed/NCBI
20	Reddy S and Aggarwal BB: Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase. FEBS Lett. 341:19–22. 1994. View Article : Google Scholar : PubMed/NCBI
21	Zhao R, Qi Y, Chen J and Zhao ZJ: FYVE-DSP2, a FYVE domain-containing dual specificity protein phosphatase that dephosphorylates phosphotidylinositol 3-phosphate. Exp Cell Res. 265:329–338. 2001. View Article : Google Scholar : PubMed/NCBI
22	Vognsen T, Möller IR and Kristensen O: Purification, crystallization and preliminary X-ray diffraction of the G3BP1 NTF2-like domain. Acta Crystallogr Sect F Struct Biol Cryst Commun. 67:48–50. 2011. View Article : Google Scholar : PubMed/NCBI
23	Bhattacharyya T, Karnezis AN, Murphy SP, Hoang T, Freeman BC, Phillips B and Morimoto RI: Cloning and subcellular localization of human mitochondrial hsp70. J Biol Chem. 270:1705–1710. 1995. View Article : Google Scholar : PubMed/NCBI
24	Mizukoshi E, Suzuki M, Loupatov A, Uruno T, Hayashi H, Misono T, Kaul SC, Wadhwa R and Imamura T: Fibroblast growth factor-1 interacts with the glucose-regulated protein GRP75/mortalin. Biochem J. 343:461–466. 1999. View Article : Google Scholar : PubMed/NCBI
25	Wadhwa R, Yaguchi T, Hasan MK, Mitsui Y, Reddel RR and Kaul SC: Hsp70 family member, mot-2/mthsp70/GRP75, binds to the cytoplasmic sequestration domain of the p53 protein. Exp Cell Res. 274:246–253. 2002. View Article : Google Scholar : PubMed/NCBI
26	Sberna AL, Assem M, Xiao R, Ayers S, Gautier T, Guiu B, Deckert V, Chevriaux A, Grober J, Le Guern N, et al: Constitutive androstane receptor activation decreases plasma apolipoprotein B-containing lipoproteins and atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol. 31:2232–2239. 2011. View Article : Google Scholar : PubMed/NCBI
27	Olszanecki R, Jawień J, Gajda M, Mateuszuk L, Gebska A, Korabiowska M, Chłopicki S and Korbut R: Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice. J Physiol Pharmacol. 56:627–635. 2005.PubMed/NCBI
28	Ramírez-Boscá A, Soler A, Carrión MA, Díaz-Alperi J, Bernd A, Quintanilla C, Quintanilla Almagro E and Miquel J: An hydroalcoholic extract of curcuma longa lowers the apo B/apo A ratio. Implications for atherogenesis prevention. Mech Ageing Dev. 119:41–47. 2000. View Article : Google Scholar : PubMed/NCBI
29	Liu C, Xu Z, Gupta D and Dziarski R: Peptidoglycan recognition proteins: A novel family of four human innate immunity pattern recognition molecules. J Biol Chem. 276:34686–34694. 2001. View Article : Google Scholar : PubMed/NCBI
30	Rohatgi A, Ayers CR, Khera A, McGuire DK, Das SR, Matulevicius S, Timaran CH, Rosero EB and de Lemos JA: The association between peptidoglycan recognition protein-1 and coronary and peripheral atherosclerosis: Observations from the Dallas Heart Study. Atherosclerosis. 203:569–575. 2009. View Article : Google Scholar : PubMed/NCBI
31	Sierra-Honigmann MR, Nath AK, Murakami C, García-Cardeña G, Papapetropoulos A, Sessa WC, Madge LA, Schechner JS, Schwabb MB, Polverini PJ, et al: Biological action of leptin as an angiogenic factor. Science. 281:1683–1686. 1998. View Article : Google Scholar : PubMed/NCBI